Farther Finance Advisors, LLC Merrimack Pharmaceuticals Inc Transaction History

Farther Finance Advisors, LLC

  • $2.67 Trillion
  • Q3 2024

A detailed history of Farther Finance Advisors, LLC transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 77 shares of MACK stock, worth $1,165. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77
Previous 77 -0.0%
Holding current value
$1,165
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
BUY
$14.68 - $15.13 $1,130 - $1,165
77 New
77 $0

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email